Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy
Abstract Oncolytic viruses (OVs) have emerged as a distinctive class of cancer therapeutics capable of coupling direct tumor cell lysis with broad immune activation, thereby reshaping antitumor immunity beyond the capacities of conventional modalities. Despite substantial progress, the clinical tran...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-03-01
|
| Серія: | Molecular Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12943-026-02651-4 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|